Search research articles
Contact Us
Filters
Showing results (151-160 of 750) with videos related to
Page
of 75
Sort By:
Alimentary Pharmacology & Therapeutics
|
June 14, 2025
Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease
Luis Antonio Díaz, Summer Collier, Jeffrey Yin, et al.
Nature Reviews. Gastroenterology & Hepatology
|
December 22, 2020
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q Huang, Hashem B El-Serag, Rohit Loomba
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 30, 2022
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q Huang, et al.
Cell Metabolism
|
March 24, 2026
The many pathways driving liver inflammation in MASH
Herbert Tilg, Timon E Adolph, Stefano Romeo, et al.
Hepatology (Baltimore, Md.)
|
December 23, 2015
Reply
Siddharth Singh, Rohan Khera, M Hassan Murad, et al.
Annual Review of Pathology
|
January 24, 2025
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction-Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong-Mi Chang, Jun Yu, et al.
Alimentary Pharmacology & Therapeutics
|
March 11, 2022
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 2, 2015
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration
Yoon Seok Roh, Bi Zhang, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)
|
August 15, 2020
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic
Naim Alkhouri, Anita Kohli, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2017
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
Rebecca G Kim, Rohit Loomba, Larry J Prokop, et al.
Page
of 75
Search research articles
Search
Showing results (151-160 of 750) with videos related to
Sort By:
Page
of 75
Alimentary Pharmacology & Therapeutics
|
June 14, 2025
Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease
Luis Antonio Díaz, Summer Collier, Jeffrey Yin, et al.
Nature Reviews. Gastroenterology & Hepatology
|
December 22, 2020
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q Huang, Hashem B El-Serag, Rohit Loomba
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 30, 2022
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q Huang, et al.
Cell Metabolism
|
March 24, 2026
The many pathways driving liver inflammation in MASH
Herbert Tilg, Timon E Adolph, Stefano Romeo, et al.
Hepatology (Baltimore, Md.)
|
December 23, 2015
Reply
Siddharth Singh, Rohan Khera, M Hassan Murad, et al.
Annual Review of Pathology
|
January 24, 2025
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction-Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong-Mi Chang, Jun Yu, et al.
Alimentary Pharmacology & Therapeutics
|
March 11, 2022
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 2, 2015
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration
Yoon Seok Roh, Bi Zhang, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)
|
August 15, 2020
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic
Naim Alkhouri, Anita Kohli, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2017
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
Rebecca G Kim, Rohit Loomba, Larry J Prokop, et al.
Page
of 75